PRA Health Sciences — Q4 2016 Earnings Presentation
17 slides from PRA Health Sciences's earnings presentation, Feb 22, 2017
Slide 1: Q4 2016 Earnings
Q4 2016 Earnings February 22, 2017
Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures
Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o
Slide 3: Q4 2016 Highlights
Q4 2016 Highlights ($ in millions, except per share amounts) $413.6 million of service revenue; 14.2% growth at actual foreign exchange rates and 14.6% constant currency growth $14.0 million of GAAP Net Income; Net Income per diluted share of $0.22 $45.9 million of Adjusted Net Income; Adjusted Net
Slide 4: Trailing Quarterly Performance
Trailing Quarterly Performance Adjusted Income from Operations ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $50.6 $56.2 $61.2 $62.4 $61.7 $67.4 $68.3 $67.8 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 16.8% 18.2% 19.3% 18.8% 18.1% 18.6% 18.7% 17.9% 15%
Slide 5: Backlog and New Business Awards
Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.20 1.21 1.25 1.27 1.28 1.25 1.30 1.42 Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 $398.0 $407.8 $431.4 $459.4 $476.2 $493.9 $519.1 $587.3 Q1 2015 Q2 2015 Q3 20
Slide 6: Debt Structure
Debt Structure * Covenant Net Debt is limited to $75 million in cash, with an additional limitation of $25 million of cash held by our foreign subsidiaries. Weighted Average ($ in millions) December 31, March 31, June 30, September 30, December 31, Interest Maturity 2015 2016 2016 2016 2016 Rate Dat
Slide 7: FY 2017 and Q1 2017 Guidance
FY 2017 and Q1 2017 Guidance FY 2017 Q1 2017 Low End of Range High End of Range Low End of Range High End of Range Service Revenue, in Millions $1,795.0 $1,835.0 $415.0 $425.0 GAAP Earnings per Diluted Share $2.46 $2.56 $0.41 $0.46 Adjusted Net Income per Diluted Share $3.08 $3.18 $0.57 $0.62 Annual
Slide 8: Appendix
Appendix PRAHEALTHSCIENCES
Slide 9: Q4 and YTD 2016 Financial Results
Q4 and YTD 2016 Financial Results ($ in millions, except per share amounts) 2016 2015 % Change 2016 2015 % Change Service Revenue 413.6 $ 362.3 $ 14.2% 1,580.0 $ 1,375.8 $ 14.8% EBITDA 54.3 $ 69.6 $ -22.0% 221.1 $ 251.5 $ -12.1% EBITDA Margin 13.1% 19.2% 14.0% 18.3% Adjusted EBITDA 73.9 $ 67.9 $ 8.8
Slide 10: Trailing Quarterly Performance
Trailing Quarterly Performance FY 16 v ($ in millions) FY 15 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Change Service Revenue 332.0 $ 336.5 $ 345.1 $ 362.3 $ 1,375.8 $ 372.3 $ 394.2 $ 399.8 $ 413.6 $ 1,580.0 $ 14.8% % growth Y-o-Y 6.6% 8.1% 7.8% 11.9% 8.6% 12.2% 17.2% 15.9% 14.2% 14.8% % growth Y-o-Y (constan
Slide 11: Backlog and New Business Awards
Backlog and New Business Awards FY 16 v ($ in millions) FY 15 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Change Beginning Backlog 2,141.1 $ 2,185.3 $ 2,262.4 $ 2,348.4 $ 2,141.1 $ 2,440.1 $ 2,552.8 $ 2,649.4 $ 2,775.6 $ 2,440.1 $ Ending Backlog 2,185.3 $ 2,262.4 $ 2,348.4 $ 2,440.1 $ 2,440.1 $ 2,552.8 $ 2,649.
Slide 12: Reconciliation of GAAP Net Income to Adjusted EBITDA
Reconciliation of GAAP Net Income to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 2016 2015 Net income 14.0 $ 28.5 $ 68.2 $ 81.8 $ Depreciation and amortization
Slide 13: Reconciliation of GAAP Net Income to Adjusted Net Income
Reconciliation of GAAP Net Income to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2016 2015 2016 2015 Net income 14.0 $ 28.5 $ 68.2 $ 81.8 $ Amo
Slide 14: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations
Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2016 2015 2016 2015 Income from operations 38.2 $ 43.9 $ 162.
Slide 15: Geographic Breakdown
Geographic Breakdown ($ in millions) Region Q4 16 Q4 15 US/Canada 241.8 214.3 Europe/Africa 132.6 112.1 Latin America 17.2 15.3 Asia/Pacific 21.9 20.6 Grand Total 413.6 362.3 60% 31% 4% 5% YTD 2016 Revenue 60% 31% 4% 5% YTD 2015 Revenue Region YTD 2016 YTD 2015 US/Canada 945.4 823.8 Europe/Africa 48
Slide 16: Days Sales Outstanding
Days Sales Outstanding ($ in millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Accounts Receivable, net 239.6 $ 281.4 $ 281.9 $ 288.3 $ 285.7 $ 320.6 $ 310.5 $ 283.4 $ Unbilled Services 132.8 115.2 118.5 126.8 134.4 142.8 136.6 155.6 Total Accounts Receivable and Unbilled Services 372.4 396.6 400.4 415.1 420.1 463.
Slide 17: PRA Health Sciences
m\/A ms PRAHEALTHSCIENCES HE FU RE OF CLINICAL DEVELOPME